Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 1 to 20 of 56

1.

Parkinson disease in the elderly adult.

Willis AW.

Mo Med. 2013 Sep-Oct;110(5):406-10. Review.

PMID:
24279192
[PubMed - indexed for MEDLINE]
2.

Cortical effects of deep brain stimulation: implications for pathogenesis and treatment of Parkinson disease.

Li Q, Qian ZM, Arbuthnott GW, Ke Y, Yung WH.

JAMA Neurol. 2014 Jan;71(1):100-3. doi: 10.1001/jamaneurol.2013.4221. Review.

PMID:
24189904
[PubMed - indexed for MEDLINE]
3.

Autonomic dysfunction in Parkinson disease.

Kaufmann H, Goldstein DS.

Handb Clin Neurol. 2013;117:259-78. doi: 10.1016/B978-0-444-53491-0.00021-3. Review.

PMID:
24095131
[PubMed - indexed for MEDLINE]
4.

Therapeutic prospects for Parkinson disease.

Olanow CW, Schapira AH.

Ann Neurol. 2013 Sep;74(3):337-47. doi: 10.1002/ana.24011. Review.

PMID:
24038341
[PubMed - indexed for MEDLINE]
5.

Surgical treatment of Parkinson disease: past, present, and future.

Duker AP, Espay AJ.

Neurol Clin. 2013 Aug;31(3):799-808. doi: 10.1016/j.ncl.2013.03.007. Epub 2013 Apr 4. Review.

PMID:
23896506
[PubMed - indexed for MEDLINE]
6.

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.

Schenck CH, Montplaisir JY, Frauscher B, Hogl B, Gagnon JF, Postuma R, Sonka K, Jennum P, Partinen M, Arnulf I, Cochen de Cock V, Dauvilliers Y, Luppi PH, Heidbreder A, Mayer G, Sixel-Döring F, Trenkwalder C, Unger M, Young P, Wing YK, Ferini-Strambi L, Ferri R, Plazzi G, Zucconi M, Inoue Y, Iranzo A, Santamaria J, Bassetti C, Möller JC, Boeve BF, Lai YY, Pavlova M, Saper C, Schmidt P, Siegel JM, Singer C, St Louis E, Videnovic A, Oertel W.

Sleep Med. 2013 Aug;14(8):795-806. doi: 10.1016/j.sleep.2013.02.016. Epub 2013 Jul 22. Erratum in: Sleep Med. 2014 Jan;15(1):157.

PMID:
23886593
[PubMed - indexed for MEDLINE]
7.

Parkinson disease and sleep: sleep-wake changes in the premotor stage of Parkinson disease; impaired olfaction and other prodromal features.

Iranzo A.

Curr Neurol Neurosci Rep. 2013 Sep;13(9):373. doi: 10.1007/s11910-013-0373-0. Review.

PMID:
23881622
[PubMed - indexed for MEDLINE]
8.

Advances in the genetics of Parkinson disease.

Trinh J, Farrer M.

Nat Rev Neurol. 2013 Aug;9(8):445-54. doi: 10.1038/nrneurol.2013.132. Epub 2013 Jul 16. Review.

PMID:
23857047
[PubMed - indexed for MEDLINE]
9.

Next-generation phenotyping using the parkin example: time to catch up with genetics.

Grünewald A, Kasten M, Ziegler A, Klein C.

JAMA Neurol. 2013 Sep 1;70(9):1186-91. doi: 10.1001/jamaneurol.2013.488. Review.

PMID:
23835509
[PubMed - indexed for MEDLINE]
10.

Recent developments in biomarkers in Parkinson disease.

Schapira AH.

Curr Opin Neurol. 2013 Aug;26(4):395-400. doi: 10.1097/WCO.0b013e3283633741. Review.

PMID:
23823465
[PubMed - indexed for MEDLINE]
11.

Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.

Perfeito R, Cunha-Oliveira T, Rego AC.

Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3. Review.

PMID:
23743292
[PubMed - indexed for MEDLINE]
12.

Rasagiline in Parkinson's disease: a review based on meta-analysis of clinical data.

Mínguez-Mínguez S, Solís-García Del Pozo J, Jordán J.

Pharmacol Res. 2013 Aug;74:78-86. doi: 10.1016/j.phrs.2013.05.005. Epub 2013 Jun 2. Review.

PMID:
23735235
[PubMed - indexed for MEDLINE]
13.

Parkinson disease and exercise.

Earhart GM, Falvo MJ.

Compr Physiol. 2013 Apr;3(2):833-48. doi: 10.1002/cphy.c100047. Review.

PMID:
23720332
[PubMed - indexed for MEDLINE]
14.

Specific needs of dopamine neurons for stimulation in order to survive: implication for Parkinson disease.

Michel PP, Toulorge D, Guerreiro S, Hirsch EC.

FASEB J. 2013 Sep;27(9):3414-23. doi: 10.1096/fj.12-220418. Epub 2013 May 22. Review.

PMID:
23699175
[PubMed - indexed for MEDLINE]
15.

Glutathione metabolism and Parkinson's disease.

Smeyne M, Smeyne RJ.

Free Radic Biol Med. 2013 Sep;62:13-25. doi: 10.1016/j.freeradbiomed.2013.05.001. Epub 2013 May 8. Review.

PMID:
23665395
[PubMed - indexed for MEDLINE]
16.

Physical activity behavior change in persons with neurologic disorders: overview and examples from Parkinson disease and multiple sclerosis.

Ellis T, Motl RW.

J Neurol Phys Ther. 2013 Jun;37(2):85-90. doi: 10.1097/NPT.0b013e31829157c0. Review.

PMID:
23632452
[PubMed - indexed for MEDLINE]
17.

Exercise: a possible adjunct therapy to alleviate early Parkinson disease.

Konerth M, Childers J.

JAAPA. 2013 Apr;26(4):30-3. Review. No abstract available.

PMID:
23610834
[PubMed - indexed for MEDLINE]
18.

Ambulation and Parkinson disease.

Amano S, Roemmich RT, Skinner JW, Hass CJ.

Phys Med Rehabil Clin N Am. 2013 May;24(2):371-92. doi: 10.1016/j.pmr.2012.11.003. Epub 2013 Jan 22. Review.

PMID:
23598269
[PubMed - indexed for MEDLINE]
19.

The role of neuroplasticity in dopaminergic therapy for Parkinson disease.

Zhuang X, Mazzoni P, Kang UJ.

Nat Rev Neurol. 2013 May;9(5):248-56. doi: 10.1038/nrneurol.2013.57. Epub 2013 Apr 16. Review.

PMID:
23588357
[PubMed - indexed for MEDLINE]
20.

The beneficial role of intensive exercise on Parkinson disease progression.

Frazzitta G, Balbi P, Maestri R, Bertotti G, Boveri N, Pezzoli G.

Am J Phys Med Rehabil. 2013 Jun;92(6):523-32. doi: 10.1097/PHM.0b013e31828cd254. Review.

PMID:
23552330
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk